At the news
? NEUTRALIMPACT 3/10 25-NSE filed Jul 15, 2026 at 09:32 ET
Nasdaq filed a 25-NSE notification to delist Nuvalent, Inc. shares following the completion of GSK plc's acquisition. The merger closed on July 15, 2026, at $124.00 per share in cash, representing a total equity value of approximately $10.6 billion. This filing is a procedural step finalizing the delisting.
- Form 25-NSE filed by Nasdaq to remove Nuvalent's Class A Common Stock from listing and registration.
- Delisting is effective as of July 15, 2026, the same day the GSK acquisition closed.
- The acquisition was completed at $124.00 per share in cash, with total equity value of approximately $10.6 billion, as reported in the prior 8-K filing.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access